Work

A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors

Year: 2024

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-24-1867

Authors: Gregory M. Cote, Bose S. Kochupurakkal, Khanh Do, Andrea Bullock, Michael L. Cheng, Alona Muzikansky, Daniel E. McLoughlin, James M. Cleary, Xin Gao, Aparna Parikh, Jong Chul Park, Colin D. Weekes, Oladapo Yeku, Lee Zou, Geoffrey I. Shapiro

Institutions: Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, University of California, San Francisco, Duke University

Language: English

Topic: DNA Repair Mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Mass General Cancer Center

OpenAlex ID: W4403761049

FWCI: 1.413

Cites: 41

Cited by: 12

Related to: 10